Antiretroviral Drugs

handshake deal shake hand arrows ok yes

Pharma

Merck prepares expanded access to monthly PrEP pill early

Merck is launching the global access strategy before the phase 3 trial evaluating alimatravir for HIV PrEP has completed enrollment or produced data.

Angus Liu Jul 24, 2026 10:40am

HIV

Gilead, Merck phase 3 data back first weekly HIV pill

Jul 21, 2026 10:00am

Gilead

Gilead's bictegravir, lenacapavir tablet meets mark in phase 3

Nov 13, 2025 9:55am

Gilead

Gilead's PrEP shows early promise in once-yearly dosing

Mar 11, 2025 2:30pm

head to head against clash football helmets fight combat

GSK's Dovato matches Gilead's Biktarvy with less weight gain

Jul 23, 2024 4:00am

Blue Cross Blue Shield of NC removes HIV drugs from costly price tiers

WHO flags increasing resistance to GSK's Tivicay in 4 countries

Mar 6, 2024 2:02pm